# Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis

> **NCT00592566** · PHASE2,PHASE3 · TERMINATED · sponsor: **Mahidol University** · enrollment: 64 (actual)

## Conditions studied

- Leptospirosis

## Interventions

- **DRUG:** Dexamethasone, desmopressin

## Key facts

- **NCT ID:** NCT00592566
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-07
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 64 (ACTUAL)
- **Why stopped:** Numbe of eligible patients has been decreased over time.
- **Last updated:** 2008-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00592566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00592566, "Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00592566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*